CLINICAL_TRIALS
trial_result
· 2021-06-23
Clinical Trial Update: A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream" [Phase 3]
Summary
Phase 3 clinical endpoint bioequivalence study of Oxymetazoline Hydrochloride Cream completed for rosacea; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actavis Inc. | Conditions: Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2021-06-23